Catarina Schiborn

Biography

Publications

• Preclinical and clinical obesity: prevalence, associations to cardiometabolic risk and response to lifestyle intervention in NHANES and the EPIC-Potsdam and TULIP studies.

  Schiborn C, Hu FB, Stefan N, Schulze MB. Nat Commun 2026 02 19

  PMID: 41714640

• Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition.

  Park JY, Van Puyvelde H, Regazzetti L, Clasen JL, Heath AK, Eussen S, Ueland PM, Johansson M, Biessy C, Zamora-Ros R, Huerta JM, Sánchez MJ, Ocke M, Schulze MB, Schiborn C, Braaten TB, Skeie G, Sacerdote C, Castilla J, Karlsson T, Johansson I, Kyrø C, Tjønneland A, Tong TYN, Katzke V, Bajracharya R, Lasheras C, Midttun Ø, Vollset SE, Vineis P, Masala G, Amiano P, Tumino R, Baldassari I, Weiderpass E, Riboli E, Gunter MJ, Freisling H, Rinaldi S, Muller DC, Huybrechts I, Ferrari P. Nutrients 2025 Jun 10

  PMID: 40573081

• Risk of cardiovascular disease in Germany: results from GEDA 2022.

  Thamm R, Du Y, Neuperdt L, Schiborn C, Maier B, Starker A, Neuhauser H, Schulze MB, Heidemann C. J Health Monit 2025

  PMID: 40475752

• EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset.

  Heinze T, Tuchtenhagen M, Knüppel S, Weber D, Pohl G, Jannasch F, Schiborn C, Schulze MB, Grune T, Schwerdtle T. J Alzheimers Dis 2025

  PMID: 40267333

• Impact of higher BMI on cardiometabolic risk: does height matter?

  Stefan N, Schiborn C, Machann J, Birkenfeld AL, Schulze MB. Lancet Diabetes Endocrinol 2024

  PMID: 38968941